| ZEYMERT, U., P. LUDMAN, N. DANCHIN, Petr KALA, C. LAROCHE, M. SADEGHI, R. CAPORALE, S. M. SHAHEEN, J. LEGUTKO, Z. IAKOBSISHVILI, K. F. ALHABIB, Z. MOTOVSKA, M. STUDENCAN, J. MIMOSO, D. BECKER, D. ALEXOPOULOS, Z. KERESESELIDZE, S. STOJKOVIC, P. ZELVEIAN, A. GODA, E. MIRRAKHIMOV, G. BAJRAKTARI, H. AL-FARHAN, P. SERPYTIS, B. RAUNGAARD, T. MARANDI, A. M. MOORE, M. QUINN, P. P. KARJALAINEN, G. TATU-CHITOLU, C. P. GALE, A. P. MAGGIONI and F. WEIDINGER. Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology. European heart journal. Oxford: Oxford University Press, 2021, vol. 42, No 44, p. 4536-4549. ISSN 0195-668X. Available from: https://dx.doi.org/10.1093/eurheartj/ehab342. |
Other formats:
BibTeX
LaTeX
RIS
@article{1834302,
author = {Zeymert, U. and Ludman, P. and Danchin, N. and Kala, Petr and Laroche, C. and Sadeghi, M. and Caporale, R. and Shaheen, S. M. and Legutko, J. and Iakobsishvili, Z. and Alhabib, K. F. and Motovska, Z. and Studencan, M. and Mimoso, J. and Becker, D. and Alexopoulos, D. and Kereseselidze, Z. and Stojkovic, S. and Zelveian, P. and Goda, A. and Mirrakhimov, E. and Bajraktari, G. and AlandFarhan, H. and Serpytis, P. and Raungaard, B. and Marandi, T. and Moore, A. M. and Quinn, M. and Karjalainen, P. P. and TatuandChitolu, G. and Gale, C. P. and Maggioni, A. P. and Weidinger, F.},
article_location = {Oxford},
article_number = {44},
doi = {http://dx.doi.org/10.1093/eurheartj/ehab342},
keywords = {ST-elevation myocardial infarction; Primary percutaneous coronary intervention; Observational studies; Reperfusion therapy},
language = {eng},
issn = {0195-668X},
journal = {European heart journal},
title = {Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology},
url = {https://academic.oup.com/eurheartj/article-abstract/42/44/4536/6352178?redirectedFrom=fulltext},
volume = {42},
year = {2021}
}
TY - JOUR
ID - 1834302
AU - Zeymert, U. - Ludman, P. - Danchin, N. - Kala, Petr - Laroche, C. - Sadeghi, M. - Caporale, R. - Shaheen, S. M. - Legutko, J. - Iakobsishvili, Z. - Alhabib, K. F. - Motovska, Z. - Studencan, M. - Mimoso, J. - Becker, D. - Alexopoulos, D. - Kereseselidze, Z. - Stojkovic, S. - Zelveian, P. - Goda, A. - Mirrakhimov, E. - Bajraktari, G. - Al-Farhan, H. - Serpytis, P. - Raungaard, B. - Marandi, T. - Moore, A. M. - Quinn, M. - Karjalainen, P. P. - Tatu-Chitolu, G. - Gale, C. P. - Maggioni, A. P. - Weidinger, F.
PY - 2021
TI - Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology
JF - European heart journal
VL - 42
IS - 44
SP - 4536-4549
EP - 4536-4549
PB - Oxford University Press
SN - 0195668X
KW - ST-elevation myocardial infarction
KW - Primary percutaneous coronary intervention
KW - Observational studies
KW - Reperfusion therapy
UR - https://academic.oup.com/eurheartj/article-abstract/42/44/4536/6352178?redirectedFrom=fulltext
N2 - Aims The aim of this study was to determine the contemporary use of reperfusion therapy in the European Society of Cardiology (ESC) member and affiliated countries and adherence to ESC clinical practice guidelines in patients with ST-elevation myocardial infarction (STEMI). Methods and results Prospective cohort (EURObservational Research Programme STEMI Registry) of hospitalized STEMI patients with symptom onset <24h in 196 centres across 29 countries. A total of 11 462 patients were enrolled, for whom primary percutaneous coronary intervention (PCI) (total cohort frequency: 72.2%, country frequency range 0-100%), fibrinolysis (18.8%; 0-100%), and no reperfusion therapy (9.0%; 0-75%) were performed. Corresponding in-hospital mortality rates from any cause were 3.1%, 4.4%, and 14.1% and overall mortality was 4.4% (country range 2.55.9%). Achievement of quality indicators for reperfusion was reported for 92.7% (region range 84.8 97.5%) for the performance of reperfusion therapy of all patients with STEMI <12h and 54.4% (region range 37.1-70.1%) for timely reperfusion. Conclusions The use of reperfusion therapy for STEMI in the ESC member and affiliated countries was high. Primary PCI was the most frequently used treatment and associated total in-hospital mortality was below 5%. However, there was geographic variation in the use of primary PCI, which was associated with differences in in-hospital mortality. [GRAPHICS] .
ER -
ZEYMERT, U., P. LUDMAN, N. DANCHIN, Petr KALA, C. LAROCHE, M. SADEGHI, R. CAPORALE, S. M. SHAHEEN, J. LEGUTKO, Z. IAKOBSISHVILI, K. F. ALHABIB, Z. MOTOVSKA, M. STUDENCAN, J. MIMOSO, D. BECKER, D. ALEXOPOULOS, Z. KERESESELIDZE, S. STOJKOVIC, P. ZELVEIAN, A. GODA, E. MIRRAKHIMOV, G. BAJRAKTARI, H. AL-FARHAN, P. SERPYTIS, B. RAUNGAARD, T. MARANDI, A. M. MOORE, M. QUINN, P. P. KARJALAINEN, G. TATU-CHITOLU, C. P. GALE, A. P. MAGGIONI and F. WEIDINGER. Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology. \textit{European heart journal}. Oxford: Oxford University Press, 2021, vol.~42, No~44, p.~4536-4549. ISSN~0195-668X. Available from: https://dx.doi.org/10.1093/eurheartj/ehab342.
|
